John Waldeisen

Entrepreneur

๐Ÿ“ Berkeley, California, United States๐Ÿ”„ Updated September 2026๐Ÿ’ผ 1 investments๐Ÿ“… 13 years investing๐Ÿ—“ Last invested Jan 2013
Operator-angel๐ŸŒ United States
1
Total investments
1
Early stage
0
Mid stage
0
Late stage
13y
Years active

Portfolio

1 investments ยท sorted by recency
All investments
Early stage
Mid stage
Late stage
Co-founder & Board Member
Jan 2013
Lucira Health has developed an at home COVID-19 test kit that delivers PCR quality molecular accuracy in the palm of your hand in 30 minutes or less. Our technology is transforming how we reduce the spread of infectious diseases by bringing accurate, easy-to-use self-testing into the home. This home test kit has not been FDA cleared or approved. This home test kit has been authorized by FDA under EUA. This home test kit has been authorized only for the testing of nasal swabs for detection of nucleic acid from SARS-CoV-2, not for any other viruses or pathogens. This home test kit is only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of IVDs for detection and/or diagnosis of COVID-19 under Section 564(b)(1) of the Act, 21 U.S.C. ยง 360bbb-3(b)(1), unless the declaration is terminated or revoked sooner.
early stageMedical Device
Experience ยท 2 entries
All (2)
Founder (2)
2019
Co-founder & CTO
Jul 2019
We leverage the power of Next Generation Sequencing (NGS) for a complete assessment of your pet's gut health.
2013
Co-founder & Board Member
Jan 2013
Lucira Health has developed an at home COVID-19 test kit that delivers PCR quality molecular accuracy in the palm of your hand in 30 minutes or less. Our technology is transforming how we reduce the spread of infectious diseases by bringing accurate, easy-to-use self-testing into the home. This home test kit has not been FDA cleared or approved. This home test kit has been authorized by FDA under EUA. This home test kit has been authorized only for the testing of nasal swabs for detection of nucleic acid from SARS-CoV-2, not for any other viruses or pathogens. This home test kit is only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of IVDs for detection and/or diagnosis of COVID-19 under Section 564(b)(1) of the Act, 21 U.S.C. ยง 360bbb-3(b)(1), unless the declaration is terminated or revoked sooner.
early stageMedical Device